Documents & Downloads

CDIBA

cPLA2 Inhibitor

CDIBA is an inhibitor of cytosolic phospholipase A2 (cPLA2) that effectively reduces the activation of this enzyme in rat diaphragm tissue. By decreasing the level of mitochondrial reactive oxygen species, CDIBA mitigates the adverse effects of prolonged mechanical ventilation. Additionally, it alleviates protein degradation, muscle atrophy, and strength decline in the diaphragm following such stress. CDIBA is valuable for research on ventilator-induced diaphragmatic dysfunction.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	479422-22-5
Applications	cPLA2 Inhibitor
Formula	C₃₁H₂₆ClNO₃
Molecular Weight	496.00
SMILES	O=C(O)C1=CC=C(OCCC=2C=3C=C(Cl)C=CC3N(C2C)C(C=4C=CC=CC4)C=5C=CC=CC5)C=C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.